{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:51:48Z","timestamp":1791503508532,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,8]],"date-time":"2027-10-08T00:00:00Z","timestamp":1822953600000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.hpb.2026.07.005","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T06:39:32Z","timestamp":1783751972000},"page":"1393-1401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genomic predictors of pathologic response to hepatic artery infusion pump chemotherapy in colorectal liver metastases"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2232-1590","authenticated-orcid":false,"given":"Naaz F.","family":"Nasar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne F.","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2869-1571","authenticated-orcid":false,"given":"Jashodeep","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya T.","family":"Evenhaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithat","family":"Gonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod P.","family":"Balachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Drebin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Peter","family":"Kingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2505-959X","authenticated-orcid":false,"given":"Alice C.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Jarnagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5643-0104","authenticated-orcid":false,"given":"Remo","family":"Alessandris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinru","family":"Shia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cercek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen M.","family":"O'Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Kemeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael I.","family":"D'Angelica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2026.07.005_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012\u2020\u2021. CA","volume":"62","author":"Siegel","year":"2012","journal-title":"A Cancer Journal for Clinicians"},{"key":"10.1016\/j.hpb.2026.07.005_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00000658-199610000-00009","article-title":"Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy","volume":"224","author":"Bismuth","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2026.07.005_bib3","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1200\/JCO.2008.19.9273","article-title":"Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?","volume":"27","author":"Adam","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hpb.2026.07.005_bib4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/hpb.12159","article-title":"Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases","volume":"16","author":"Devaud","year":"2014","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hpb.2026.07.005_bib5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/SLA.0b013e31819a0486","article-title":"Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil\/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases","volume":"249","author":"Masi","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2026.07.005_bib6","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1245\/s10434-011-2061-0","article-title":"A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases","volume":"19","author":"Lam","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2026.07.005_bib7","first-page":"160","article-title":"Conversion chemotherapy for unresectable colorectal liver metastases: are we making a difference?","volume":"11","author":"Mokdad","year":"2015","journal-title":"Curr Colorectal Cancer Rep"},{"key":"10.1016\/j.hpb.2026.07.005_bib8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamasurg.2019.1694","article-title":"Role of hepatic artery infusion chemotherapy in treatment of initially unresectable colorectal liver metastases: a review","volume":"154","author":"Datta","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.hpb.2026.07.005_bib9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1634\/theoncologist.8-6-553","article-title":"An update on hepatic arterial infusion chemotherapy for colorectal cancer","volume":"8","author":"Cohen","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.hpb.2026.07.005_bib10","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1200\/JCO.1994.12.11.2288","volume":"12","author":"Kemeny","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hpb.2026.07.005_bib11","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1200\/JCO.2008.20.1301","article-title":"Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma","volume":"27","author":"Kemeny","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hpb.2026.07.005_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/SLA.0000000000000614","article-title":"Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes","volume":"261","author":"D\u02bcAngelica","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2026.07.005_bib13","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1200\/JCO.2008.17.5299","article-title":"Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases","volume":"26","author":"Blazer","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hpb.2026.07.005_bib14","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1245\/s10434-012-2335-1","article-title":"Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome","volume":"19","author":"Poultsides","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2026.07.005_bib15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12893-020-00738-3","article-title":"Tumor response and outcome after reverse treatment for patients with synchronous colorectal liver metastasis: a cohort study","volume":"20","author":"Du Pasquier","year":"2020","journal-title":"BMC Surg"},{"key":"10.1016\/j.hpb.2026.07.005_bib16","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.7150\/jca.47911","article-title":"The characteristics and long-term survival of patients with colorectal liver metastases with pathological complete response after chemotherapy","volume":"11","author":"Xu","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.hpb.2026.07.005_bib17","doi-asserted-by":"crossref","first-page":"7950","DOI":"10.1245\/s10434-023-14073-3","article-title":"Combined hepatic arterial infusion pump and systemic chemotherapy in the modern era for chemotherapy-naive patients with unresectable colorectal liver metastases","volume":"30","author":"Verheij","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2026.07.005_bib18","first-page":"10434","article-title":"Computed tomography-based radiomics with machine learning outperforms radiologist assessment in estimating colorectal liver metastases pathologic response after chemotherapy","author":"Karagkounis","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2026.07.005_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJMoa033025","article-title":"Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer","volume":"351","author":"Cunningham","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hpb.2026.07.005_bib20","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1200\/JCO.2005.10.017","article-title":"Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer","volume":"23","author":"Hurwitz","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hpb.2026.07.005_bib21","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1200\/JCO.2007.14.7116","article-title":"Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer","volume":"26","author":"Amado","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hpb.2026.07.005_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.hpb.2026.07.005_bib23","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1200\/JCO.2011.38.2994","article-title":"Comparative genomic analysis of primary versus metastatic colorectal carcinomas","volume":"30","author":"Vakiani","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hpb.2026.07.005_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ccell.2017.12.004","article-title":"Clinical sequencing defines the genomic landscape of metastatic colorectal cancer","volume":"33","author":"Yaeger","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.hpb.2026.07.005_bib25","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.3390\/ijms22115561","article-title":"High concordance of genomic profiles between primary and metastatic colorectal cancer","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hpb.2026.07.005_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/biomedicines9010039","article-title":"Recent advances in monoclonal antibody therapy for colorectal cancers","volume":"9","author":"Hwang","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.hpb.2026.07.005_bib27","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1097\/SLA.0000000000004613","article-title":"Distinct genomic profiles are associated with conversion to resection and survival in patients with initially unresectable colorectal liver metastases treated with systemic and hepatic artery chemotherapy","volume":"276","author":"Datta","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2026.07.005_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.hpb.2019.03.368","article-title":"KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver Metastases","volume":"21","author":"Margonis","year":"2019","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2026.07.005_bib29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases","volume":"230","author":"Fong","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2026.07.005_bib30","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1001\/jama.2009.1755","article-title":"Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases","volume":"302","author":"Chun","year":"2009","journal-title":"JAMA"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X26006994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X26006994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:21:10Z","timestamp":1791501670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X26006994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1365182X26006994"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2026.07.005","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic predictors of pathologic response to hepatic artery infusion pump chemotherapy in colorectal liver metastases","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2026.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}